JAMA Otolaryngology –Head & Neck Surgery : Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer
Interview with Evan M. Graboyes, MD, MPH, author of Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - April 25, 2024 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
The Evolution of Screening Tools for Prostate Cancer
The utility of prostate-specific antigen (PSA) screening for prostate cancer detection is impacted by detection of cancers with low risk of mortality. Editorialist Jeffrey J. Tosoian, MD, MPH, discusses a pragmatic approach to prostate cancer screening with JAMA Deputy Editor Mary L. (Nora) Disis, MD. Related Content: A Pragmatic Approach to Prostate Cancer Screening Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - April 6, 2024 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Transplant Recipients: Consider Skin Cancer, Infection Risks
Recent research sheds light on varying skin cancer risk, and a predictive tool offers guidance on screening in solid organ transplant recipients. (Source: Medscape Transplantation Podcast)
Source: Medscape Transplantation Podcast - April 5, 2024 Category: Transplant Surgery Authors: Medscape 210869 Source Type: podcasts
Audio long read: Why are so many young people getting cancer? What the data say
Around the world, rates of cancers that typically affect older adults are increasing in those under 50 years old. Models based on global data predict that the number of early-onset cancer cases like these will increase by around 30% between 2019 and 2030.The most likely contributors — such as rising rates of obesity and early-cancer screening — do not fully account for the increase. To try and understand the reasons behind this trend, many researchers are searching for answers buried in studies that tracked the lives and health of children born half a century ago.This is an audio version of our Feature Why are so many ...
Source: Nature Podcast - April 5, 2024 Category: Science Authors: Springer Nature Limited Source Type: podcasts
LAA Ligation for AFib, Tumor-Infiltrating Lymphocytes in Breast Cancer, Anomalous Health Incidents, and more
Editor’s Summary by Anthony Charles, MD, MPH, Associate Editor of JAMA, the Journal of the American Medical Association, for the April 2, 2024, issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - April 2, 2024 Category: General Medicine Authors: JAMA Network Source Type: podcasts
JAMA Oncology : Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time
Interview with Tobias Janowitz, MD, PhD, and Karen Winkfield, MD, PhD, authors of Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time. Hosted by Vivek Subbiah, MD. Related Content: Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - March 21, 2024 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
TWiV 1095: Monkeys fly and mice exaggerate
TWiV reviews heterosexual transmission of clade I Mpox virus, continued circulation of oropouche virus in South America, herpesviruses in South American fur seals and sea lions, sex-specific differences in physiological responses to SARS-CoV-2 infection, underdetected dispersal and extensive local transmission drove the 2022 mpox epidemic, and a humanized mouse model for adenovirus-associated virus gene therapy. Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Angela Mingarelli Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode M...
Source: This Week in Virology - MP3 Edition - March 10, 2024 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
JAMA Oncology : Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor –Positive Breast Cancer
Interview with José P. Leone, MD, author of Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer. Hosted by Nora L. (Mary) Disis, MD. Related Content: Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 29, 2024 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
TWiV 1090: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin reviews recent statistics on the circulation of respiratory syncytial virus before discussing uptake of the RSV vaccine Abrysvo or the monoclonal anti-RSV antibody nirsevimab to prevent severe disease following RSV infection in infants 8 months or younger before going over this week’s influenza virus and SARS-CoV-2 virus statistics, including all circulating variants in the US, examines if self-testing is more accurate than clinician administered Binax rapid diagnostic tests for SARS-CoV-2 infection, if N95 masks need a yearly fitting, how SARS-CoV-2 vaccination impacts the prev...
Source: This Week in Virology - MP3 Edition - February 24, 2024 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Tools on the Horizon for Managing Posttransplant cSCC Risk
Organ transplant recipients have a 200-fold increased incidence of keratinocyte carcinoma compared with immunocompetent individuals, and cSCC accounts for 80% of skin cancers in those recipients. (Source: Medscape Transplantation Podcast)
Source: Medscape Transplantation Podcast - February 9, 2024 Category: Transplant Surgery Authors: Medscape 210869 Source Type: podcasts
Why we need to rethink how we talk about cancer
For over a century, cancer has been classified by areas of the body - lung cancer, breast cancer, skin cancer etc. And yet modern medical research is telling us that the molecular and genetic mechanisms behind cancers are not necessarily tied to parts of the body. Many drugs developed to treat metastatic cancers have the capacity to work across many different cancers, and that presents an opportunity for more tailored and efficient treatments. Oncologists are calling for a change in the way patients, clinicians and regulators think about naming cancers.In this podcast, senior comment editor Lucy Odling-...
Source: Nature Podcast - February 9, 2024 Category: Science Authors: Springer Nature Limited Source Type: podcasts
Cancer's power harnessed — lymphoma mutations supercharge T cells
In this episode:0:46 Borrowing tricks from cancer could help improve immunotherapyT cell based immunotherapies have revolutionised the treatment of certain types of cancer. However these therapies — which involved taking someone’s own T cells and reprogramming them to kill cancer cells — have struggled to treat solid tumours, which put up multiple defences. To overcome these, a team has taken mutations found in cancer cells that help them thrive and put them into therapeutic T cells. Their results show these powered-up cells are more efficient at targeting solid tumours, but don’t turn cancerous themselves.Research...
Source: Nature Podcast - February 7, 2024 Category: Science Authors: Springer Nature Limited Source Type: podcasts
COVID-19 Vaccination in Pregnancy and in Children, Climate Change and Health Series, Thyroid Cancer Review, and more
Editor’s Summary by Christopher W. Seymour, MD, MSc, Associate Editor of JAMA, the Journal of the American Medical Association, for the February 6, 2024, issue. Related Content: Audio Highlights (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - February 6, 2024 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Cervical cancer could be eliminated: here's how
Cervical cancer is both treatable and preventable, and the WHO has called for countries to come together to to eliminate the disease in the next century.However the disease still kills over 300,000 people each year, and levels of screening, treatment and vaccination need to be stepped up in order to achieve this goal.These challenges are particularly stark in low- and middle-income countries, where a lack of funding, staffing and infrastructure are obstacles. Vaccine hesitancy, especially in light of the COVID-19 pandemic, is also a key problem.In this Podcast Extra, two experts share their thoughts on how best to overcome...
Source: Nature Podcast - February 4, 2024 Category: Science Authors: Springer Nature Limited Source Type: podcasts
TWiV 1980: AI builds better viruses
TWiV reviews global measles outbreaks, toilet-generated aerosols that spread viruses, highly effective prevention of invasive cervical cancer by HPV vaccination, and design of improved adenovirus-associated viral vectors using machine learning. Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, and Rich Condit Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode MicrobeTV Discord Server MicrobeTV store at Cafepress Become a member of ASV (asv.org) Research assistant position in Rosenfeld Lab CBER/FDA (pdf) The New City by Dickson Despommier Jay Nel...
Source: This Week in Virology - MP3 Edition - January 28, 2024 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
